Search - tctmd.com

Displaying 21 - 40 of 115

Sort: Relevancy | Date

Presentation TCT 2019

Nonrheumatic MAC-Related Mitral Stenosis and Balloon Valvuloplasty

Presenter: Igor Palacios

September 28, 2019

Presentation TCT 2019

MAC Types and Clinical Implications

Presenter: Philipp Blanke

September 28, 2019

Presentation TCT 2019

What Can We Learn From MRI About FMR Proportionality?

Presenter: Michael Salerno

September 28, 2019

Presentation TCT 2019

Advantages and Limitations of MRI for MR Assessment at Baseline and Post-MitraClip

Presenter: Joao Cavalcante

September 28, 2019

Presentation TCT 2019

Nonesophageal Mitral Echo Imaging

Presenter: Stephen Little

September 28, 2019

Presentation TCT 2019

Advanced Mitral Imaging, Intraprocedural Guidance, and Image Fusion Technologies

Presenter: Rhonda Miyasaka

September 28, 2019

Presentation TCT 2019

State of the Art: FMR Severity Assessment by Quantitative Echo

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

State of the Art: DMR Severity Assessment by Quantitative Echo

Presenter: Burkhart Mackensen

September 28, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Combination Valve Treatments (MR and TR/MR and AS): Rationale, Sequence, and Results

Presenter: Georg Nickenig

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Presentation TCT 2019

Contemporary Antiplatelet/Anticoagulation Therapy Post-PCI

Presenter: Sorin Brener

September 25, 2019

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

News Conference News ESC 2019

GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib

Todd Neale

September 12, 2019

Advertisement

Nonrheumatic MAC-Related Mitral Stenosis and Balloon Valvuloplasty

MAC Types and Clinical Implications

What Can We Learn From MRI About FMR Proportionality?

Advantages and Limitations of MRI for MR Assessment at Baseline and Post-MitraClip

Nonesophageal Mitral Echo Imaging

Advanced Mitral Imaging, Intraprocedural Guidance, and Image Fusion Technologies

State of the Art: FMR Severity Assessment by Quantitative Echo

State of the Art: DMR Severity Assessment by Quantitative Echo

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Combination Valve Treatments (MR and TR/MR and AS): Rationale, Sequence, and Results

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

TCT 2019 Day Two: Transcatheter Valves, New and Old

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Contemporary Antiplatelet/Anticoagulation Therapy Post-PCI

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content